MODERATORS: Mina Tadrous | Chioma Ejekam
Longitudinal Associations Between Body Mass Index and Disease Activity, and Radiographic Progression in Rheumatoid Arthritis Patients Receiving Infliximab 
Theresa Burkard | Enriqueta Vallejo-Yagüe | Kim Lauper | Axel Finckh | Thomas Hügle | Andrea Burden (United Kingdom)
A Pilot Evaluation of Switchback from Biosimilars to Originator-Biologics in the Veterans Affairs Population: A Signal of Biosimilar Failure?
Kelly Bryan | Qoua Her | Diane Dong | Rong Jiang | Jennifer Martin | Fran Cunningham (United States)
Decreased Discontinuation and Switching of b/tsDMARDs in RA When Treatment Aligns with Molecular Signature Response Classifier Results: An Analysis from the Study to Accelerate Information of Molecular Signatures (AIMS) 
Jeffrey Curtis | Lixia Zhang | Johanna Withers | Sam Asgarian (United States)
Trends in Initiation Patterns of Disease-Modifying Therapies for Multiple Sclerosis Among Commercially Insured Adults and Children in the United States, 2001-2020 
Chintan Dave | Mackenzie Henderson | Daniel Horton | Vikram Bhise | Gian Pal | Greta Bushnell (United States)
Integration of Immuno-oncology (IO) Treatments into Routine Clinical Practice for the Treatment of Patients with Advanced or Metastatic Cancers: Analysis of the England National Cancer Registry
Hamid Mahmoudpour | Craig Knott | Amerah Amin | Emmanuelle Boutmy | Patrice Verpillat (Germany)
The Use Of Denosumab and the Risk of Incidence of Diabetes in Patients with Osteoporosis
Albert Tzu-Ming Chuang | Huei-Kai Huang | Tzu-Chi Liao | Peter Pin-Sung Liu | Shih-Chieh Shao | Edward Chia-Cheng Lai (Taiwan)